Kyung Hae Jung

Neoadjuvant atezolizumab in combination with sequential nab-paclitaxel and anthracycline-based chemotherapy versus placebo and chemotherapy in patients with early-stage triple-negative breast cancer (IMpassion031): a randomised, double-blind, phase 3 trial

Elizabeth A. Mittendorf, Hong Zhang, Carlos H. Barrios et al. · The Lancet · 2020 · 1K citations · Full text

Breast Oncology, Oncology, Breast Cancer +6

Open versus laparoscopic surgery for mid or low rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): short-term outcomes of an open-label randomised controlled trial

Sung‐Bum Kang, Ji Won Park, Seung‐Yong Jeong et al. · The Lancet Oncology · 2010 · 1K citations

Low Rectal Cancer, Surgical Oncology, Gastrointestinal Oncology +8

Ribociclib plus endocrine therapy for premenopausal women with hormone-receptor-positive, advanced breast cancer (MONALEESA-7): a randomised phase 3 trial

Debu Tripathy, Seock‐Ah Im, Marco Colleoni et al. · The Lancet Oncology · 2018 · 973 citations

Advanced Breast Cancer, Breast Oncology, Oncology +11

Open versus laparoscopic surgery for mid-rectal or low-rectal cancer after neoadjuvant chemoradiotherapy (COREAN trial): survival outcomes of an open-label, non-inferiority, randomised controlled trial

Seung‐Yong Jeong, Ji Won Park, Byung Ho Nam et al. · The Lancet Oncology · 2014 · 878 citations

Low-rectal Cancer, Surgical Oncology, Neoadjuvant Chemoradiotherapy +10

Efficacy and Safety of Trastuzumab Deruxtecan in Patients With HER2-Expressing Solid Tumors: Primary Results From the DESTINY-PanTumor02 Phase II Trial

Funda Meric‐Bernstam, Vicky Makker, Ana Oaknin et al. · Journal of Clinical Oncology · 2023 · 767 citations · Full text